Cargando…
Inhibition of Hepatitis B Virus and Induction of Hepatoma Cell Apoptosis by ASGPR-Directed Delivery of shRNAs
Hepatitis B virus (HBV) infection is a worldwide liver disease and nearly 25% of chronic HBV infections terminate in hepatocellular carcinoma (HCC). Currently, there is no effective therapy to inhibit HBV replication and to eliminate hepatoma cells, making it highly desired to develop novel therapie...
Autores principales: | Ma, Jingwei, Huang, Chunmei, Yao, Xinxin, Shi, Chuan, Sun, Lifang, Yuan, Lu, Lei, Ping, Zhu, Huifen, Liu, Hongbo, Wu, Xiongwen, Ning, Qin, Zhou, Chun, Shen, Guanxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477153/ https://www.ncbi.nlm.nih.gov/pubmed/23094023 http://dx.doi.org/10.1371/journal.pone.0046096 |
Ejemplares similares
-
Generation of shRNAs from randomized oligonucleotides
por: Wu, Hailong, et al.
Publicado: (2007) -
Towards Antiviral shRNAs Based on the AgoshRNA Design
por: Liu, Ying Poi, et al.
Publicado: (2015) -
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
por: Karim, Md. Emranul, et al.
Publicado: (2018) -
96 shRNAs designed for maximal coverage of HIV-1 variants
por: Mcintyre, Glen John, et al.
Publicado: (2009) -
Prediction of ultra-potent shRNAs with a sequential classification algorithm
por: Pelossof, Raphael, et al.
Publicado: (2017)